Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIG-A Mutation in Breast Cancer Chemotherapy
NCT03837054Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jan 2019
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoints: Frequency of reticulocytes PIG-A mutated at 24 months and Binucleated cell micronuclei frequency in culture at 24 months. Status: unknown.
Beyond the preview
Go deeper on NCT03837054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03837054.